Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
topic: Access to Medicines
MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
Read More
MSF’s Mobile Response Team: Bringing mental health support to Kashmir
Read More
Bringing mental health care to Kashmir
Read More
India: Bringing mental health support to Kashmir
Read More
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries
Read More
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Read More
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
Read More
MSF South Asia Health and Humanity Summit: Partnering to build better responses during emergencies
Read More
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
Read More
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
Read More